QP 04 - H&N 4: Pitching Clinically-focused Research to Improve Outcomes and Prognostication

Moderator(s)

• MY

  Melissa Young, MD, PhD

  Yale University School of Medicine
  New Haven, CT, United States
• 

  Neal Dunlap, MD

  University of Louisville
  Louisville, KY

Presentations:

• 5:00 PM – 5:05 PM ET

  Introduction
• 5:05 PM – 5:10 PM ET

  Dose-Escalated Hypofractionated Adaptive Radiotherapy (DEHART) and 60 Gy in 15 Fractions for Advanced Head and Neck Cancers: An Interim Analysis of a Phase I Trial
  

  Presenter: Musaddiq Awan, MD – Medical College of Wisconsin
• 5:10 PM – 5:15 PM ET

  Neoadjuvant Chemoimmunotherapy Followed by Surgery and Response-Adapted Adjuvant Radiotherapy for Head and Neck Squamous Cell Carcinoma
  

  Presenter: Yuan Wu, MD – Hubei Cancer Hospital
• 5:15 PM – 5:20 PM ET

  Oxygen-Enhanced MRI in Patients with p16-Positive Oropharyngeal Cancer Undergoing (Chemo)-Radiotherapy
  

  Presenter: James Price, MBBS, FRCR – The Christie NHS Foundation Trust
• 5:20 PM – 5:25 PM ET

  Prognostic Value of Image-Identified Extranodal Extension and Potential Role in Cn Classification in HPV-Negative Oropharyngeal Cancer: A Multi-Center Cohort Study
  

  Presenter: Shao Hui Huang, MS, RT – Princess Margaret Cancer Centre
• 5:25 PM – 5:30 PM ET

  ACRIN 6685 PET-CT Threshold to Reinterpret Pre-Treatment Head and Neck Cancer (HNC) Imaging? Stage Migration and Treatment Outcomes
  

  Presenter: Nuverah Mohsin, MD, BS – Fox Chase Cancer Center
• 5:30 PM – 5:35 PM ET

  Treatment Response-Adapted Risk Index Model for Survival Prediction and Adjuvant Chemotherapy Selection in Nonmetastatic Nasopharyngeal Carcinoma
  

  Presenter: Yang Liu, MD – Cancer Hospital Chinese Academy of Medical Sciences
• 5:35 PM – 5:55 PM ET

  Questions and Answers
• 5:55 PM – 6:00 PM ET

  Closing